1. Volume 81, Issue 6, Pages 568-576 (March 2012)
Renal outcomes in hypertensive Black patients at high cardiovascular risk 
Matthew R. Weir, George L. Bakris, Michael A. Weber, Bjorn Dahlof, Richard B. Devereux, Sverre E. Kjeldsen, Bertram Pitt, Jackson T. Wright, Roxzana Y. Kelly, Tsushung A. Hua, R Allen Hester, Eric Velazquez, Kenneth A. Jamerson 
Kidney International 
Volume 81, Issue 6, Pages (March 2012)
DOI: /ki
Copyright © 2012 International Society of Nephrology Terms and Conditions

2. Figure 1
Kaplan–Meier curves for the composite end point of more than 50% increase in serum creatinine or adjudicated renal end point—by self-described ethnicity (US patients).
Kidney International  , DOI: ( /ki )
Copyright © 2012 International Society of Nephrology Terms and Conditions

3. Figure 2
Mean change from baseline in estimated glomerular filtration rate (eGFR) by race/ethnicity and treatment groups (US patients); slope difference calculated from baseline between B+A and B+H in Blacks (P<0.02) and non-Blacks (P<0.0001). B+A, benazepril and amlodipine; B+H, benazepril and hydrochlorothiazide; Blk, Black; CI, 95% confidence interval.
Kidney International  , DOI: ( /ki )
Copyright © 2012 International Society of Nephrology Terms and Conditions

4. Figure 3
Mean change from month 3 in estimated glomerular filtration rate (eGFR)—by race/ethnicity and treatment group (US patients); slope difference between B+A and B+H calculated from month 3: Blacks (P=0.785) and non-Blacks (P=0.022). B+A, benazepril and amlodipine; B+H, benazepril and hydrochlorothiazide; Blk, Black; CI, 95% confidence interval.
Kidney International  , DOI: ( /ki )
Copyright © 2012 International Society of Nephrology Terms and Conditions

5. Figure 4
Kaplan–Meier curves for the composite end point of >50% increase from month 3 in serum creatinine or adjudicated renal end point after month 3—by race/ethnicity and treatment group (US patients). B+A, benazepril and amlodipine; B+H, benazepril and hydrochlorothiazide; Blk, Black.
Kidney International  , DOI: ( /ki )
Copyright © 2012 International Society of Nephrology Terms and Conditions

6. Figure 5
Mean change from month 3 in estimated glomerular filtration rate (eGFR)—by treatment group (US patients); slope difference calculated from month 3 between B+A and B+H is P= B+A, benazepril and amlodipine; B+H, benazepril and hydrochlorothiazide; Blk, Black; CI, 95% confidence interval.
Kidney International  , DOI: ( /ki )
Copyright © 2012 International Society of Nephrology Terms and Conditions